MassARRAY assay: a more accurate method for JAK2V617F mutation detection in Chinese patients with myeloproliferative disorders

被引：0
|
作者：
J-F Fu
J-Y Shi
W-L Zhao
G Li
Q Pan
J-M Li
J Hu
Z-X Shen
J Jin
F-Y Chen
S-J Chen
机构：
[1] State Key Laboratory of Medical Genomics,Department of Hematology
[2] Shanghai Institute of Hematology,undefined
[3] Shanghai Rui Jin Hospital,undefined
[4] Shanghai Jiao Tong University School of Medicine,undefined
[5] Zhejiang Institute of Hematology,undefined
[6] The First Affiliated Hospital,undefined
[7] Medical School of Zhejiang University,undefined
[8] Shanghai Ren Ji Hospital,undefined
[9] Shanghai Jiao Tong University School of Medicine,undefined
来源：
Leukemia | 2008年 / 22卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：660 / 663
页数：3
相关论文
共 50 条
  • [31] Discussion of the correlation between JAK2V617f mutation and thromboembolism in myeloproliferative neoplasm patients
    Xia, L.
    Wu, J-S
    Ding, K-Y
    Zeng, Q-S
    Cai, X-Y
    Zhu, W-B
    Wu, L-L
    Liu, X.
    Yang, H-Z
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 635 - 636
  • [32] Detection of the activating JAK2V617F mutation in paraffin-embedded bone marrow biopsies of patients with chronic myeloproliferative disorders
    Horn, T
    Kremer, M
    Dechow, T
    Pfeifer, WM
    Geist, B
    Duyster, J
    Quintanilla-Martinez, L
    Fend, F
    LABORATORY INVESTIGATION, 2006, 86 : 229A - 230A
  • [33] Detection of the activating JAK2V617F mutation in paraffin-embedded bone marrow biopsies of patients with chronic myeloproliferative disorders
    Horn, T
    Kremer, M
    Dechow, T
    Pfeifer, WM
    Geist, B
    Duyster, J
    Quintanilla-Martinez, L
    Fend, F
    MODERN PATHOLOGY, 2006, 19 : 229A - 230A
  • [34] Myeloproliferative disorders "Philadelphia negative" and JAK2V617F mutation: study of 15 cases in Togo
    Padaro, Essohana
    Agbetiafa, Kossi
    Kueviakoe, Irenee Messanh Delagnon
    Layibo, Yao
    Amegbor, Koffi
    Vovor, Ahoefa
    Giraudier, Stephane
    Sanogo, Ibrahima
    Segbena, Akuete Yvon
    ANNALES DE BIOLOGIE CLINIQUE, 2012, 70 (05) : 591 - 594
  • [35] JAK2V617F mutation in leukaemic transformation of Philadelphia negative chronic myeloproliferative disorders.
    Rossi, Davide
    Deambrogi, Clara
    Capello, Daniela
    Cerri, Michaela
    Lunghi, Monia
    De Paoli, Lorenzo
    Parvis, Guido
    Saglio, Giuseppe
    Gaidano, Gianluca
    Cilloni, Daniela
    BLOOD, 2006, 108 (11) : 1030A - 1030A
  • [36] JAK2V617F mutation in patients with arterial thrombosis in the absence of overt myeloproliferative disease
    Dentali, F.
    Squizzato, A.
    Appio, L.
    Brivio, L.
    Ageno, W.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (04) : 722 - 725
  • [37] JAK2V617F mutation in patients with arterial thrombosis in the absence of overt myeloproliferative disease
    Dentali, F.
    Squizzato, A.
    Appio, L.
    Brivio, L.
    Ageno, W.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 740 - 740
  • [38] Platelet function studies in myeloproliferative neoplasms patients with Calreticulin or JAK2V617F mutation
    Guy, Alexandre
    Helzy, Khalil
    Mansier, Olivier
    Bordet, Jean-Claude
    Riviere, Etienne
    Fiore, Mathieu
    James, Chloe
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2023, 7 (02)
  • [39] Transgenic expression of JAK2V617F causes myeloproliferative disorders in mice
    Xing, Shu
    Ho, Wanting Tina
    Zhao, Wanming
    Ma, Junfeng
    Wang, Shaofeng
    Xu, Xuesong
    Li, Qingshan
    Fu, Xueqi
    Xu, Mingjiang
    Zhao, Zhizhuang Joe
    BLOOD, 2008, 111 (10) : 5109 - 5117
  • [40] Transgenic expression of JAK2V617F causes myeloproliferative disorders in mice
    Xing, Shu
    Zhao, Zhizhuang Joe
    BLOOD, 2007, 110 (11) : 745A - 745A
12345